Relx (NYSE:RELX – Get Free Report) is anticipated to post its H1 2026 resultson Thursday, July 23rd. Analysts expect the company to announce earnings of $0.8940 per share and revenue of $6.5365 billion for the quarter. Interested persons can find conference call details on the company’s upcoming H1 2026 earning report page for the latest details on the call scheduled for Thursday, July 23, 2026 at 2:00 AM ET.
Relx Stock Performance
RELX stock opened at $33.52 on Thursday. Relx has a twelve month low of $27.57 and a twelve month high of $54.02. The company has a quick ratio of 0.44, a current ratio of 0.49 and a debt-to-equity ratio of 2.38. The business has a 50 day moving average of $32.75 and a 200 day moving average of $34.54.
Institutional Trading of Relx
Several institutional investors have recently added to or reduced their stakes in the business. Transamerica Financial Advisors LLC raised its stake in shares of Relx by 3,040.0% in the fourth quarter. Transamerica Financial Advisors LLC now owns 785 shares of the technology company’s stock worth $32,000 after purchasing an additional 760 shares during the last quarter. Measured Wealth Private Client Group LLC purchased a new stake in shares of Relx during the third quarter valued at $72,000. Horizon Investments LLC boosted its position in shares of Relx by 23.0% during the third quarter. Horizon Investments LLC now owns 1,517 shares of the technology company’s stock valued at $72,000 after buying an additional 284 shares during the last quarter. Brown Brothers Harriman & Co. increased its holdings in Relx by 66.4% in the 4th quarter. Brown Brothers Harriman & Co. now owns 2,410 shares of the technology company’s stock worth $97,000 after buying an additional 962 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in Relx in the 4th quarter worth about $114,000. 15.02% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Check Out Our Latest Stock Analysis on Relx
Relx Company Profile
RELX plc is a global provider of information, analytics and decision tools for professional and business customers. The company supplies content, data and analytical services that support decision-making across scientific, technical and medical research, legal and regulatory practice, and risk and business analytics. RELX’s offerings are largely delivered via digital platforms and subscription services designed for institutions, corporations and professionals who require specialized, high-value information and workflow solutions.
RELX operates through distinct business lines that include Elsevier, which provides scientific, technical and medical journals, books and online platforms such as research and discovery tools; Legal and Professional services, which deliver legal, regulatory and compliance content and workflow solutions; Risk & Business Analytics, which offers data, analytics and decision tools for insurance, banking, corporate and government risk assessment; and Exhibitions, which organizes industry trade shows and events.
Featured Stories
- Five stocks we like better than Relx
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.
